中山醫學大學機構典藏 CSMUIR:Item 310902500/24056
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 17918/22933 (78%)
造访人次 : 7429911      在线人数 : 55
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.csmu.edu.tw:8080/ir/handle/310902500/24056


    题名: The dawn phenomenon in type 2 diabetes: its association with glucose excursions and changes after oral glucose-lowering drugs
    作者: Wang, JS;Lee, IT;Lee, WJ;Lin, SD;Su, SL;Tu, ST;Lin, SY;Sheu, WHH
    关键词: continuous glucose monitoring;dawn phenomenon;glucose excursions;type 2 diabetes
    日期: 2021
    上传时间: 2022-08-05T09:47:07Z (UTC)
    出版者: SAGE PUBLICATIONS LTD
    ISSN: 2040-6223
    摘要: Background: We investigated the association between glucose excursions and the dawn phenomenon, and the effects of oral-glucose lowering drugs on the dawn phenomenon in patients with type 2 diabetes (T2D). Methods: We conducted a post hoc analysis using data from a previous randomized trial. Patients with T2D on metformin monotherapy were randomized to receive add-on acarbose or glibenclamide for 16 weeks. Ambulatory continuous glucose monitoring (CGM) was conducted before randomization and at the end of the study. Using the CGM data, we assessed glucose excursions as indicated by mean amplitude of glycemic excursions (MAGE). The magnitude of the dawn phenomenon was calculated as the difference between the nocturnal nadir (0:00 to 6:00 a.m.) and prebreakfast glucose level. Results: A total of 50 patients with T2D [mean age 53.5 +/- 8.2 years, mean glycated hemoglobin (HbA1c) 8.4 +/- 1.2%] were analyzed. There was an independent association between MAGE and the dawn phenomenon [beta coefficient 0.199, 95% confidence interval (CI) 0.074-0.325, p = 0.003]. HbA1c improved significantly after treatment with acarbose or glibenclamide. However, only treatment with acarbose significantly improved glucose excursions. The dawn phenomenon decreased significantly only in patients treated with acarbose (from 35.9 +/- 15.7-28.3 +/- 16.5 mg/dl, p = 0.037), but not in those treated with glibenclamide (from 35.9 +/- 20.6-34.6 +/- 17.0 mg/dl, p = 0.776). Conclusion: Glucose excursions were independently associated with the dawn phenomenon in patients with T2D on metformin monotherapy. Both glucose excursions and the dawn phenomenon improved after treatment with acarbose, but not after treatment with glibenclamide.
    URI: http://dx.doi.org/10.1177/20406223211033674
    https://www.webofscience.com/wos/woscc/full-record/WOS:000694880700001
    https://ir.csmu.edu.tw:8080/handle/310902500/24056
    關聯: THERAPEUTIC ADVANCES IN CHRONIC DISEASE ,2021,v12
    显示于类别:[中山醫學大學研究成果] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML153检视/开启


    SFX Query

    在CSMUIR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈